Medifast, Inc. (NYSE:MED) Shares Sold by Trexquant Investment LP

Trexquant Investment LP cut its position in shares of Medifast, Inc. (NYSE:MED - Free Report) by 44.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 58,304 shares of the specialty retailer's stock after selling 47,206 shares during the period. Trexquant Investment LP owned 0.53% of Medifast worth $1,027,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Public Employees Retirement System of Ohio increased its position in shares of Medifast by 1,161.8% in the third quarter. Public Employees Retirement System of Ohio now owns 9,766 shares of the specialty retailer's stock valued at $187,000 after buying an additional 8,992 shares in the last quarter. Nisa Investment Advisors LLC lifted its holdings in Medifast by 2,308.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 11,442 shares of the specialty retailer's stock valued at $202,000 after purchasing an additional 10,967 shares in the last quarter. Exchange Traded Concepts LLC increased its stake in shares of Medifast by 4.1% during the fourth quarter. Exchange Traded Concepts LLC now owns 17,106 shares of the specialty retailer's stock worth $301,000 after purchasing an additional 674 shares in the last quarter. XTX Topco Ltd purchased a new position in Medifast in the 3rd quarter valued at about $348,000. Finally, Amundi acquired a new stake in Medifast in the 4th quarter worth about $374,000. Hedge funds and other institutional investors own 95.51% of the company's stock.

Medifast Stock Performance

Shares of MED stock traded down $0.23 during trading hours on Wednesday, reaching $12.15. The company had a trading volume of 32,264 shares, compared to its average volume of 323,258. The stock has a fifty day moving average of $14.10 and a 200-day moving average of $16.51. The company has a market capitalization of $132.91 million, a price-to-earnings ratio of 67.50 and a beta of 1.05. Medifast, Inc. has a 12-month low of $12.13 and a 12-month high of $36.30.

Medifast (NYSE:MED - Get Free Report) last announced its earnings results on Tuesday, February 18th. The specialty retailer reported $0.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.16) by $0.26. The company had revenue of $119.00 million for the quarter, compared to analyst estimates of $114.25 million. Medifast had a return on equity of 10.64% and a net margin of 0.35%. On average, analysts forecast that Medifast, Inc. will post 0.51 EPS for the current year.

Wall Street Analyst Weigh In

Separately, DA Davidson dropped their price target on Medifast from $17.00 to $16.50 and set a "neutral" rating for the company in a research report on Wednesday, February 19th.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.